Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive.

NCT02281448 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: BIA 2-093
DRUG: Contraceptives, Oral, Combined

Sponsor

Bial - Portela C S.A.